Pôsobí na: zdravie čreva, protizápalovo, antioxidačne

Bromelín je enzým extrahovaný z ananásov. Môže znížiť pálenie záhy a pôsobiť proti upchatiu nosa.


Dávkovanie závisí od cieľa, kvôli ktorému sa bromelín užíva. Na pomoc so zažívaním sa štandardne užíva dávka 200-2000 mg spolu s jedlom. Ak sa užíva kvôli iným účinkom, tak sa dávka pohybuje v rozmedzí 200-800 mg a užíva sa medzi jedlami aby sa zabránilo jeho degradácii v žalúdku.

Medicínske upozornenie!


  1. Mialovyts’ka OA. Effect of phlogenzym in long-term treatment of patients with multiple sclerosisLik Sprava. (2003)
  2. Kerkhoffs GM, et al. A double blind, randomised, parallel group study on the efficacy and safety of treating acute lateral ankle sprain with oral hydrolytic enzymesBr J Sports Med. (2004)
  3. Shahid SK, et al. Efficacy and safety of phlogenzym–a protease formulation, in sepsis in childrenJ Assoc Physicians India. (2002)
  4. Szczurko O, et al. Naturopathic treatment of rotator cuff tendinitis among Canadian postal workers: a randomized controlled trialArthritis Rheum. (2009)
  5. Rowan AD, Buttle DJ. Pineapple cysteine endopeptidasesMethods Enzymol. (1994)
  6. Maurer HR. Bromelain: biochemistry, pharmacology and medical useCell Mol Life Sci. (2001)
  7. Harrach T, et al. Isolation and partial characterization of basic proteinases from stem bromelainJ Protein Chem. (1995)
  8. Purification and characterization of multiple forms of the pineapple-stem-derived cysteine proteinases ananain and comosain.
  9. Irene D, et al. Resonance assignments and secondary structure of a phytocystatin from Ananas comosusBiomol NMR Assign. (2012)
  10. Yoshioka S, et al. Inactivation kinetics of enzyme pharmaceuticals in aqueous solutionPharm Res. (1991)
  11. Ketnawa S, Chaiwut P, Rawdkuen S. Extraction of bromelain from pineapple peelsFood Sci Technol Int. (2011)
  12. Castell JV, et al. Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intakeAm J Physiol. (1997)
  13. Bioavailability of Therapeutically used Hydrolytic Enzymes.
  14. White RR, et al. Bioavailability of 125I bromelain after oral administration to ratsBiopharm Drug Dispos. (1988)
  15. Dave S, et al. Hexafluoroisopropanol-induced helix-sheet transition of stem bromelain: correlation to functionInt J Biochem Cell Biol. (2010)
  16. Hale LP, Haynes BF. Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activationJ Immunol. (1992)
  17. Roxas M. The role of enzyme supplementation in digestive disordersAltern Med Rev. (2008)
  18. Pellicano R, et al. Benefit of dietary integrators for treating functional dyspepsia: a prospective pilot studyMinerva Gastroenterol Dietol. (2009)
  19. Borrelli F, et al. Inhibitory effects of bromelain, a cysteine protease derived from pineapple stem (Ananas comosus), on intestinal motility in miceNeurogastroenterol Motil. (2011)
  20. Hale LP, et al. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel diseaseClin Immunol. (2005)
  21. CD44 antibody against In(Lu)-related p80, lymphocyte-homing receptor molecule inhibits the binding of human erythrocytes to T cells.
  22. Scheffel JW, Kim YB. Characterization of autologous erythrocyte rosette-forming cells in Minnesota miniature swineCell Immunol. (1981)
  23. Mahajan S, et al. Stem Bromelain-Induced Macrophage Apoptosis and Activation Curtail Mycobacterium tuberculosis PersistenceJ Infect Dis. (2012)
  24. Hale LP, Greer PK, Sempowski GD. Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activationClin Immunol. (2002)
  25. Fitzhugh DJ, et al. Bromelain treatment decreases neutrophil migration to sites of inflammationClin Immunol. (2008)
  26. Mynott TL, et al. Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cellsJ Immunol. (1999)
  27. Kalra N, et al. Regulation of p53, nuclear factor kappaB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skinToxicol Appl Pharmacol. (2008)
  28. Bhui K, et al. Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathwayCancer Lett. (2009)
  29. Majima M, et al. Determination of bradykinin-(1-5) in inflammatory exudate by a new ELISA as a reliable indicator of bradykinin generationInflamm Res. (1996)
  30. Ogino M, et al. Increased migration of neutrophils to granulocyte-colony stimulating factor in rat carrageenin-induced pleurisy: roles of complement, bradykinin, and inducible cyclooxygenase-2Inflamm Res. (1996)
  31. Wittenborg A, et al. Comparative epidemiological study in patients with rheumatic diseases illustrated in a example of a treatment with non-steroidal anti- inflammatory drugs versus an oral enzyme combination preparationArzneimittelforschung. (2000)
  32. Masson M. Bromelain in blunt injuries of the locomotor system. A study of observed applications in general practiceFortschr Med. (1995)
  33. Akhtar NM, et al. Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee–a double-blind prospective randomized studyClin Rheumatol. (2004)
  34. Inoue K, et al. Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formationProstaglandins Leukot Essent Fatty Acids. (1994)
  35. Buford TW, et al. Protease supplementation improves muscle function after eccentric exerciseMed Sci Sports Exerc. (2009)
  36. Miller PC, et al. The effects of protease supplementation on skeletal muscle function and DOMS following downhill runningJ Sports Sci. (2004)
  37. Neumayer C, et al. Combined enzymatic and antioxidative treatment reduces ischemia-reperfusion injury in rabbit skeletal muscleJ Surg Res. (2006)
  38. Roep BO, et al. Modulation of autoimmunity to beta-cell antigens by proteasesDiabetologia. (2002)
  39. Kempf K, et al. Effect of combined oral proteases and flavonoid treatment in subjects at risk of Type 1 diabetesDiabet Med. (2009)
  40. Metzig C, et al. Bromelain proteases reduce human platelet aggregation in vitro, adhesion to bovine endothelial cells and thrombus formation in rat vessels in vivoIn Vivo. (1999)
  41. Heinicke RM, van der Wal L, Yokoyama M. Effect of bromelain (Ananase) on human platelet aggregationExperientia. (1972)
  42. Felton GE. Fibrinolytic and antithrombotic action of bromelain may eliminate thrombosis in heart patientsMed Hypotheses. (1980)
  43. Ley CM, et al. A review of the use of bromelain in cardiovascular diseasesZhong Xi Yi Jie He Xue Bao. (2011)
  44. Juhasz B, et al. Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardiumAm J Physiol Heart Circ Physiol. (2008)
  45. Gaciong Z, et al. Beneficial effect of proteases on allograft arteriosclerosis in a rat aortic modelNephrol Dial Transplant. (1996)
  46. Seligman B. Oral bromelains as adjuncts in the treatment of acute thrombophlebitisAngiology. (1969)
  47. Gutfreund AE, Taussig SJ, Morris AK. Effect of oral bromelain on blood pressure and heart rate of hypertensive patientsHawaii Med J. (1978)
  48. Seneviratne AN, Sivagurunathan B, Monaco C. Toll-like receptors and macrophage activation in atherosclerosisClin Chim Acta. (2012)
  49. Lauer D, Reichenbach A, Birkenmeier G. Alpha 2-macroglobulin-mediated degradation of amyloid beta 1–42: a mechanism to enhance amyloid beta catabolismExp Neurol. (2001)
  50. Baumhackl U, et al. A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosisMult Scler. (2005)
  51. Dave S, et al. Inhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytesPLoS One. (2012)
  52. Seltzer AP. Adjunctive use of bromelains in sinusitis: a controlled studyEye Ear Nose Throat Mon. (1967)
  53. Ryan RE. A double-blind clinical evaluation of bromelains in the treatment of acute sinusitisHeadache. (1967)
  54. Taub SJ. The use of bromelains in sinusitis: a double-blind clinical evaluationEye Ear Nose Throat Mon. (1967)
  56. Braun JM, Schneider B, Beuth HJ. Therapeutic use, efficiency and safety of the proteolytic pineapple enzyme Bromelain-POS in children with acute sinusitis in GermanyIn Vivo. (2005)
  57. NEUBAUER RA. A plant protease for potentiation of and possible replacement of antibioticsExp Med Surg. (1961)
  58. Grabovac V, Bernkop-Schnürch A. Improvement of the intestinal membrane permeability of low molecular weight heparin by complexation with stem bromelainInt J Pharm. (2006)
  59. Guggi D, Bernkop-Schnürch A. Improved paracellular uptake by the combination of different types of permeation enhancersInt J Pharm. (2005)
  60. Renzini G, Varengo M. Absorption of tetracycline in presence of bromelain after oral administrationArzneimittelforschung. (1972)
  61. Bradbrook ID, Morrison PJ, Rogers HJ. The effect of bromelain on the absorption of orally administered tetracyclineBr J Clin Pharmacol. (1978)
  62. Volatile Components of Pineapple.
  63. Montero-Calderón M, Rojas-Graü MA, Martín-Belloso O. Aroma profile and volatiles odor activity along gold cultivar pineapple fleshJ Food Sci. (2010)
  65. Klein G, et al. Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugsClin Exp Rheumatol. (2006)
  66. Brien S, et al. Bromelain as an adjunctive treatment for moderate-to-severe osteoarthritis of the knee: a randomized placebo-controlled pilot studyQJM. (2006)
  67. Stone MB, et al. Preliminary comparison of bromelain and Ibuprofen for delayed onset muscle soreness managementClin J Sport Med. (2002)
  68. Walker AF, et al. Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adultsPhytomedicine. (2002)
  69. Tilwe GH, et al. Efficacy and tolerability of oral enzyme therapy as compared to diclofenac in active osteoarthrosis of knee joint: an open randomized controlled clinical trialJ Assoc Physicians India. (2001)